[HTML][HTML] Could a lipid oxidative biomarker be applied to improve risk stratification in the prevention of cardiovascular disease?

MVMB Pimentel, A Bertolami, LP Fernandes… - Biomedicine & …, 2023 - Elsevier
There is significant evidence demonstrating the influence of oxidative stress on
atherosclerosis and cardiovascular diseases (CVD). However, oxidative biomarkers have …

Adipokines and their potential impacts on susceptibility to myocardial ischemia/reperfusion injury in diabetes

R Han, H Huang, J Zhu, X **, Y Wang, Y Xu… - Lipids in Health and …, 2024 - Springer
Coronary artery disease has a high mortality rate and is a striking public health concern,
affecting a substantial portion of the global population. On the early onset of myocardial …

Correlation between the triglyceride-to-high-density lipoprotein cholesterol ratio and other unconventional lipid parameters with the risk of prediabetes and type 2 …

T Yang, Y Liu, L Li, Y Zheng, Y Wang, J Su… - Cardiovascular …, 2022 - Springer
Objective Type 2 diabetes mellitus (T2DM) is often accompanied by undiagnosed
dyslipidemia. Research on the association of unconventional lipid markers with prediabetes …

Correlations between acute coronary syndrome and novel inflammatory markers (systemic immune-inflammation index, systemic inflammation response index, and …

A Tuzimek, EA Dziedzic, J Beck… - Journal of Inflammation …, 2024 - Taylor & Francis
Purpose Type 2 diabetes mellitus (DM) is a recognized independent risk factor for both
chronic coronary syndrome (CCS) and its complication, acute coronary syndrome (ACS) …

Association of sodium-glucose cotransporter 2 inhibitors with risk of major adverse cardiovascular events in type 2 diabetes patients with acute coronary syndrome: a …

T Liu, Z Fan, B **ao, C He, S Wang - Cardiovascular Diabetology, 2024 - Springer
Background This study aimed to investigate the association of sodium-glucose cotransporter
2 inhibitors (SGLT2i) use with cardiovascular (CV) clinical outcomes in type 2 diabetes …

[HTML][HTML] Myocardial viability testing in the management of ischemic heart failure

EE Babes, DM Tit, AF Bungau, C Bustea, M Rus… - Life, 2022 - mdpi.com
Although major advances have occurred lately in medical therapy, ischemic heart failure
remains an important cause of death and disability. Viable myocardium represents a cause …

Diagnosis and management of type 2 diabetes mellitus in patients with ischaemic heart disease and acute coronary syndromes-a review of evidence and …

MU Shah, A Roebuck, B Srinivasan, JK Ward… - Frontiers in …, 2025 - frontiersin.org
Type 2 diabetes mellitus (T2DM) represents a major healthcare condition of the 21st century.
It is characterised by persistently elevated blood glucose occurring as a result of peripheral …

[HTML][HTML] Diabetes mellitus in acute coronary syndrome

PK Stampouloglou, A Anastasiou, E Bletsa, S Lygkoni… - Life, 2023 - mdpi.com
The global prevalence of diabetes mellitus (DM) has led to a pandemic, with significant
microvascular and macrovascular complications including coronary artery disease (CAD) …

Long-term PM2. 5 exposure associated with severity of angina pectoris and related health status in patients admitted with acute coronary syndrome: Modification effect …

Z Chu, Y Zhang, B Guo, X Zhang, Y Cao, H Ji… - Environmental …, 2024 - Elsevier
Long-term particulate matter with aerodynamic diameters≤ 2.5 μm (PM 2.5) exposure has
been associated with the occurrence of acute coronary syndrome (ACS). However, the …